These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 10919667)
1. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells. Kominsky SL; Hobeika AC; Lake FA; Torres BA; Johnson HM Cancer Res; 2000 Jul; 60(14):3904-8. PubMed ID: 10919667 [TBL] [Abstract][Full Text] [Related]
2. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells. Gooch JL; Herrera RE; Yee D Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines. Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641 [TBL] [Abstract][Full Text] [Related]
4. HER-2/neu raises SHP-2, stops IFN-gamma anti-proliferation in bladder cancer. Su WP; Tu IH; Hu SW; Yeh HH; Shieh DB; Chen TY; Su WC Biochem Biophys Res Commun; 2007 Apr; 356(1):181-6. PubMed ID: 17346677 [TBL] [Abstract][Full Text] [Related]
5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related]
7. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Salnikow K; Costa M; Figg WD; Blagosklonny MV Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Chen B; He L; Savell VH; Jenkins JJ; Parham DM Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323 [TBL] [Abstract][Full Text] [Related]
9. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations. Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351 [TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Zhou BP; Liao Y; Xia W; Spohn B; Lee MH; Hung MC Nat Cell Biol; 2001 Mar; 3(3):245-52. PubMed ID: 11231573 [TBL] [Abstract][Full Text] [Related]
11. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate. Huang Y; Horvath CM; Waxman S Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311 [TBL] [Abstract][Full Text] [Related]
12. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells. Blagosklonny MV; Prabhu NS; El-Deiry WS Cancer Res; 1997 Jan; 57(2):320-5. PubMed ID: 9000576 [TBL] [Abstract][Full Text] [Related]
13. Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. Moffatt KA; Johannes WU; Hedlund TE; Miller GJ Cancer Res; 2001 Oct; 61(19):7122-9. PubMed ID: 11585744 [TBL] [Abstract][Full Text] [Related]
14. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. Yu S; Wang X; Ng CF; Chen S; Chan FL Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420 [TBL] [Abstract][Full Text] [Related]
15. IFI16 in human prostate cancer. Alimirah F; Chen J; Davis FJ; Choubey D Mol Cancer Res; 2007 Mar; 5(3):251-9. PubMed ID: 17339605 [TBL] [Abstract][Full Text] [Related]
16. Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Zhang L; Hung MC Oncogene; 1996 Feb; 12(3):571-6. PubMed ID: 8637714 [TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein signaling in prostate cancer cell lines. Brubaker KD; Corey E; Brown LG; Vessella RL J Cell Biochem; 2004 Jan; 91(1):151-60. PubMed ID: 14689587 [TBL] [Abstract][Full Text] [Related]
19. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products. Chen L; Zhang W; Fregien N; Pierce M Oncogene; 1998 Oct; 17(16):2087-93. PubMed ID: 9798679 [TBL] [Abstract][Full Text] [Related]
20. Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. Harvat BL; Jetten AM Cell Growth Differ; 1996 Mar; 7(3):289-300. PubMed ID: 8838859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]